Bosnia and Herzegovina vs Russian Federation: Percentage of bloodstream infection due to methicillin-resistant
Bosnia and Herzegovina
26.5%
in 2022
Russian Federation
17.0%
in 2021
Bosnia and Herzegovina rank
25th
Russian Federation rank
27th
Percentage of bloodstream infection due to methicillin-resistant over time
- Bosnia and Herzegovina
- Russian Federation
How they compare
Bosnia and Herzegovina currently reports 26.5% against 17.0% in Russian Federation, a difference of 9.5%.
That makes Bosnia and Herzegovina's figure about 1.6 times Russian Federation's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 25th and Russian Federation ranks 27th of 50 countries.
Russian Federation has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.6% | 19.1% | 1.5% | Russian Federation |
| 2020s | 22.0% | 23.0% | 0.9% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Bosnia and Herzegovina or Russian Federation?
- Bosnia and Herzegovina, at 26.5% against 17.0% in Russian Federation as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Bosnia and Herzegovina and Russian Federation?
- 9.5%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Russian Federation?
- 5 years are reported by both, from 2017 to 2021.
- How do Bosnia and Herzegovina and Russian Federation rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Bosnia and Herzegovina ranks 25th and Russian Federation ranks 27th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.